Correlation Between Abcellera Biologics and STATE

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Abcellera Biologics and STATE at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Abcellera Biologics and STATE into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Abcellera Biologics and STATE STREET P, you can compare the effects of market volatilities on Abcellera Biologics and STATE and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Abcellera Biologics with a short position of STATE. Check out your portfolio center. Please also check ongoing floating volatility patterns of Abcellera Biologics and STATE.

Diversification Opportunities for Abcellera Biologics and STATE

-0.58
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Abcellera and STATE is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Abcellera Biologics and STATE STREET P in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on STATE STREET P and Abcellera Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Abcellera Biologics are associated (or correlated) with STATE. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of STATE STREET P has no effect on the direction of Abcellera Biologics i.e., Abcellera Biologics and STATE go up and down completely randomly.

Pair Corralation between Abcellera Biologics and STATE

Given the investment horizon of 90 days Abcellera Biologics is expected to under-perform the STATE. In addition to that, Abcellera Biologics is 9.42 times more volatile than STATE STREET P. It trades about -0.03 of its total potential returns per unit of risk. STATE STREET P is currently generating about 0.06 per unit of volatility. If you would invest  8,826  in STATE STREET P on September 2, 2024 and sell it today you would earn a total of  253.00  from holding STATE STREET P or generate 2.87% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy98.41%
ValuesDaily Returns

Abcellera Biologics  vs.  STATE STREET P

 Performance 
       Timeline  
Abcellera Biologics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Abcellera Biologics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. Despite quite weak fundamental indicators, Abcellera Biologics disclosed solid returns over the last few months and may actually be approaching a breakup point.
STATE STREET P 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days STATE STREET P has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, STATE is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Abcellera Biologics and STATE Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Abcellera Biologics and STATE

The main advantage of trading using opposite Abcellera Biologics and STATE positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Abcellera Biologics position performs unexpectedly, STATE can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in STATE will offset losses from the drop in STATE's long position.
The idea behind Abcellera Biologics and STATE STREET P pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Other Complementary Tools

Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
CEOs Directory
Screen CEOs from public companies around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance